In critical care, tackling organ failures in real-time with an integrated and personalized approach is the priority road to effectively face diseases such as: sepsis, renal failure, respiratory and multi-organ failure in general, and all diseases with mortality rates still above 50%. AMPLYA™ is a multitherapeutic system for critical care. Integration of multiple extracorporeal treatments - from the more conventional to adsorption treatments - widens the therapeutic opportunities in case of organ failure.
A wide therapeutic choice
The history of Bellco in many ways identifies with the history of extracorporeal blood purification: constant commitment and passion at the service of Collaborative Research. Paying attention and listening to the needs of the medical-scientific community together with know-how and innovative capability make it possible to take another step forward on the road to excellence.
The current and future challenges in critical care require intuitive, versatile systems able to respond to the clinical needs in real-time.
AMPLYA™: A LIFE-SAVING SYSTEM
AMPLYA™ is capable of performing a vast number of extracorporeal blood clearance treatments with one single circuit. For each specific disease, an unprecedented integrated therapeutic approach that can aid patient survival and improve the quality of life.
AMPLYA™: a real and complete multitherapeutic system
A single platform for multiple options:
- CRRT (SCUF, CVVH, CVVHD, CVVHDF)
- IRRT (IHF-HVHF, IHD SLED, IHDF)
- CO₂ REMOVAL (ABYLCAP)
- HP - HEMOPERFUSION
The added value of AMPLYA™
Completeness | Automation | Intuitiveness
For patients that may be victims of diseases such as: ALI (Acute Lung Injury); RHEUMATOID ARTHRITIS; ARDS (Acute Respiratory Distress Syndrome); COBP (Chronic Obstructive Bronchopneumopathy); CRUSH SYNDROME; HYPERCHOLESTEROLEMIA; ARF (Acute Renal Failure); MYASTHENIA GRAVIS; MYELOMA; MOF: MULTI-ORGAN DYSFUNCTION (Renal, Hepatic, Cardiac, Pulmonary And Cerebral); IMMUNE COMPLEX DISEASES; SEVERE SEPSIS; SEPTIC SHOCK.
Selective clearance: beyond the known Patterns
Just as the organism in physiological conditions retains noble substances and eliminates waste products, so selective clearance in pathological conditions can be truly effective if it retains noble substances and eliminates toxic ones. Develop new clearance technologies, increasingly effective in providing therapeutic support for complex diseases. This is the commitment of the Collaborative Research of universities, clinics and the industry, also testified by the F.A.R.E. Project: Filtration and Adsorption Regione Emilia-Romagna.
The soul of AMPLYA™: selective clearance
The blood is the tissue that connects the organs. It allows for the cellular survival, regulation and growth thereby controlling the functionality of each organ. It transports nutrients and allows removing the waste products of cellular metabolism. Complementary use of filtration and adsorption allows removing from the blood the molecules involved in organ damage without losing noble substances, such as albumin, and can encourage functional recovery of the organ. AMPLYA™ intervenes in this process by associating the specific treatment with the individual disease. The soul of AMPLYA™ is an innovative concept born of the Collaborative Research between University, Clinic and the Industry.
A NEW VIEW OF THE ACUTE PATIENT
Technological innovation, the wide range of therapies and ease of use are the essential features of Lynda®.
Lynda® does the CPFA® therapy (Coupled Plasma Filtration Adsorption) dedicated to the treatment of sepsis and it is able to do renal disease’s treatments (continuous or intermittent) such as isolated ultrafiltration, hemofiltration, hemodialysis and hemodiafiltration other than plasma exchange treatments.
All treatments done by Lynda® are safely managed thanks to the following technical features:
- Continual monitoring of hematocrit and oxygen saturation
- High autonomy of up to 40 litres of solution with possibility of pre and post-dilution
- Software user-friendly with automatic priming
- Direct interface with touch screen
- High visibility display with “on-line guide”
- “plug & play” operation with pre-assembled kit with integrated filter and lines
- History file with 300 hours of memory
- Heater of infusion/dialysate fluid with settable temperature between 30 and 40°C